| Dr Brendan Thomas Gorman, DO | |
|
301 University Blvd, Galveston, TX 77555-0540 | |
| (409) 772-2091 | |
| (409) 772-5144 |
| Full Name | Dr Brendan Thomas Gorman |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 301 University Blvd, Galveston, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336709625 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | BP10068816 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brendan Thomas Gorman, DO 301 University Blvd, Galveston, TX 77555-0540 Ph: (409) 772-2091 | Dr Brendan Thomas Gorman, DO 301 University Blvd, Galveston, TX 77555-0540 Ph: (409) 772-2091 |
News Archive
Worldwide Innovative Network (WIN) in personalized cancer medicine consortium today proudly announced that Pfizer, Inc (NYSE:PFE) is the first pharmaceutical company to become a member of the consortium. Founded on the recognition that greater success can be achieved through collaboration than any organization can achieve alone, the WIN Consortium is a global network of leading academic, industry, and patient advocacy organizations working to make personalized cancer care a reality for patients worldwide.
The preliminary analysis of penalties would lower Medicare payments to these hospitals by 1 percent for a year. Elsewhere, lawmakers introduce legislation to change how hospitals that serve a large number of poor patients are affected by Medicare's penalties.
Correctly and quickly diagnosing malaria is essential for effective and life-saving treatment. But rapid detection, particularly in remote areas, is not always possible because current methods are time-consuming and require precise instrumentation and highly skilled microscopic analysis. Now, a promising new optical imaging system, described in a paper published today in the Optical Society's (OSA) open-access journal Biomedical Optics Express, may make the diagnosis of this deadly disease much easier, faster, and more accurate.
Adding an artificial tumor-specific receptor to immune system cells called T-lymphocytes that target a particular virus extended and improved the cells' ability to fight a form of childhood cancer called neuroblastoma, said researchers form Baylor College of Medicine and Texas Children's Hospital in a report that appears online in the journal Nature Medicine.
The U.S. Food and Drug Administration today warned patients and healthcare providers about the potential for increased risk of muscle injury from the cholesterol-lowering medication Zocor (simvastatin) 80 mg.
› Verified 5 days ago
Dr. Mehraban Kavoussi, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1005 Harborside Dr F5, Galveston, TX 77555 Phone: 409-772-9605 | |
Dr. Jonathan A. Gerber, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1005 Harborside Dr, Galveston, TX 77555 Phone: 409-772-6781 | |
Dr. Joseph Sonstein, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 | |
Sidney A Worsham Iii, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 | |
Eduardo Orihuela, M.D. Urology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-0817 Fax: 409-772-0885 | |
Dr. Laith Alzweri, MBBS Urology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd., Utmb Health Urology- Galveston, Galveston, TX 77555 Phone: 409-772-9605 |